Amiodarone Hydrochloride Injection, Solution
Product Images NDC 68083-112

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Amiodarone Hydrochloride (NDC 68083-112). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Gland Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Amiodarone-spl-inner-carton-label (Amiodarone Spl Inner Carton Label)

This is a description of a medication called HCI Injection, USP which is supplied as a sterile, nonpyrogenic, and PVC-free 3 mL single-dose syringe. It must be diluted and used only for intravenous use. The usual dosage is not specified and should be referred to the package insert. The medication contains 50 mg amiodarone HCI, 100 mg polysorbate 80, NF, and 20.2 mg benzyl alcohol, NF in water for injection, USP per mL. It should be stored at 20° to 25°C (68° to 77°F) and protected from light and excessive heat. This medication has been manufactured by Gland Pharma Limited in Hyderabad, India.*

FDA Label Image

Amiodarone-spl-outer-carton-label (Amiodarone Spl Outer Carton Label)

HCI Injection, USP is a sterile and nonpyrogenic injection that must be diluted for intravenous use only. It comes in 10 x 3mL single-dose syringes free of DEHP and PVC. The container closure is made without natural rubber latex. Each mL contains 50mg amiodarone HCI, 100mg polysorbate 80 NF, 20.2mg benzyl alcohol NF in water for injection, USP. The usual dosage should be followed as per the package insert. It must be stored at 20° to 25°C, protected from light and excessive heat, and should not be frozen. The product is produced by Gland Pharma Limited based in Hyderabad, India.*

FDA Label Image

Amiodarone-spl-pfs-label (Amiodarone Spl Pfs Label)

This is a label or instruction for a medication manufactured by Gland Pharma Limited in Hyderabad, India. The medication contains 50mg of an unknown substance per mL and must be diluted before use. The label also indicates that it is intended for intravenous use only. No information is provided on the purpose or recommended dosage of the medication.*

FDA Label Image

Amiodarone-spl-structure (Amiodarone Spl Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.